Senti Biosciences, Inc.(SNTI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SNTI Senti Biosciences, Inc.

Trading 10-07 13:34:02 EDT

0.3249

+0.0019

+0.59%

High0.3299	Low0.3130	Vol68.53K
Open0.3131	D1 Closing0.3230	Amplitude5.23%
Mkt Cap10.12M	Tradable Cap4.74M	Total Shares31.14M
T/O21.86K	T/O Rate0.47%	Tradable Shares14.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SNTI","market":"US","secType":"STK","nameCN":"Senti Biosciences, Inc.","latestPrice":0.3249,"timestamp":1791394258257,"preClose":0.323,"halted":0,"volume":68531,"delay":0,"changeRate":0.00588235294117651,"floatShares":14577400,"shares":31144500,"eps":-1.713579,"marketStatus":"Trading","change":0.0019,"latestTime":"10-07 13:34:02 EDT","open":0.3131,"high":0.3299,"low":0.313,"amount":21855.82770935,"amplitude":0.052322,"askPrice":0.3249,"askSize":400,"bidPrice":0.3176,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.713579,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791403200000},"marketStatusCode":2,"adr":0,"listingDate":1622001600000,"exchange":"NASDAQ","adjPreClose":0.323,"preHourTrading":{"tag":"盘前","latestPrice":0.3129,"preClose":0.323,"latestTime":"08:42 EDT","volume":2601,"amount":815.65003494,"timestamp":1791376947309,"change":-0.0101,"changeRate":-0.031269,"amplitude":0.055108},"postHourTrading":{"tag":"盘后","latestPrice":0.323,"preClose":0.323,"latestTime":"19:53 EDT","volume":14966,"amount":4861.5034,"timestamp":1791330815226,"change":0,"changeRate":0,"amplitude":0.019814},"volumeRatio":0.384627},"requestUrl":"/m/hq/s/SNTI/","defaultTab":"news","newsList":[{"id":"2670490023","title":"Senti Biosciences Board Member Brenda Cooperstone Resigns, Steps Down as Compensation Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490023","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490023?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:04","pubTimestamp":1790280273,"startTime":"0","endTime":"0","summary":"Senti Biosciences board member Brenda Cooperstone resigns, steps down as compensation committee chairBrenda Cooperstone resigned from Senti Biosciences’ board on Sept. 23, 2026, effective immediately.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL7lpD9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664970335","title":"Senti Biosciences Unit Issues USD 2 Million Senior Secured Convertible Notes to NSG BioInnovation Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2664970335","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664970335?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:05","pubTimestamp":1788516300,"startTime":"0","endTime":"0","summary":"Senti Biosciences unit issues USD 2 million senior secured convertible notes to NSG BioInnovation FundSenti Holdings, a Senti Biosciences unit, closed a USD 2 million sale of Senior Secured Convertibl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL8jcGMQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","BK4539","BK4022","CGIP","SNTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849068","title":"Senti Biosciences Authorizes $2 Million Senior Secured Convertible Note Issuance to NSG BioInnovation Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849068","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849068?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:31","pubTimestamp":1788381069,"startTime":"0","endTime":"0","summary":"Senti Biosciences authorizes $2 million senior secured convertible note issuance to NSG BioInnovation FundSenti Biosciences amended its securities purchase agreement to allow additional tranches of Mi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5CJwpR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661906232","title":"Senti Biosciences Unit Issues USD 4 Million Senior Secured Convertible Notes to Celadon Partners SPV 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2661906232","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661906232?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:26","pubTimestamp":1787257588,"startTime":"0","endTime":"0","summary":"Senti Biosciences unit issues USD 4 million senior secured convertible notes to Celadon Partners SPV 24Senti Holdings, a unit of Senti Biosciences Holdings, issued USD 4 million of Senior Secured Conv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDLwj4KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121467","title":"Senti Biosciences Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121467","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121467?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:02","pubTimestamp":1786741336,"startTime":"0","endTime":"0","summary":"Senti Biosciences Holdings Inc reports results for the quarter ended June 30 - Earnings SummarySenti Biosciences Holdings IncSNTI.OQreported a quarterly adjusted loss of 41 cents per share for the qua","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B1LH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNTI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129597","title":"Senti Biosciences Q2 Net Loss Narrows to $12.75 Million; Revenue Turns to $17,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129597","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129597?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:17","pubTimestamp":1786738635,"startTime":"0","endTime":"0","summary":"Senti Biosciences Q2 net loss narrows to $12.75 million; revenue turns to $17,000Senti Biosciences Holdings posted a Q2 net loss of USD 12.75 million, narrowing from USD 14.73 million a year earlier.R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL5ZD2MQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651468895","title":"Senti Bio announces transaction to spin off Gene-Circuit-enabled pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2651468895","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651468895?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116828,"startTime":"0","endTime":"0","summary":"Senti Bio (SNTI) announced a strategic transaction designed to sharpen its focus on next-generation controllable genetic medicines powered by its R...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/senti-bio-announces-transaction-to-spin-off-gene-circuit-enabled-pipeline-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/senti-bio-announces-transaction-to-spin-off-gene-circuit-enabled-pipeline-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SNTI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651450838","title":"Senti Biosciences to Spin Off Senti-202 Assets to Celadon-backed Newco for CVR Worth up to $60 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2651450838","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651450838?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:31","pubTimestamp":1784115063,"startTime":"0","endTime":"0","summary":"Senti Biosciences to spin off SENTI-202 assets to Celadon-backed NewCo for CVR worth up to $60 millionCeladon-controlled NewCo to acquire Senti Biosciences Holdings’ Gene-Circuit pipeline assets, incl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL1GDn47:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BN0W2W23.USD","BK4539","NDAQ","SG9999014005.SGD","SNTI","LU2210150020.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014039.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BCDF","IE00BN0W2T93.GBP","BK4588","BK4112","SG9999014013.SGD","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR","SG9999014021.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651457700","title":"Senti Biosciences - CVR Milestones: $10 Mln for Bla Filing, $20 Mln for FDA Approval, $30 Mln for $200 Mln Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2651457700","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651457700?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:30","pubTimestamp":1784115011,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0VO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651145705","title":"Senti Biosciences - Newco to Buy Gene-circuit Pipeline Including Senti-202 for CVR up to $60 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2651145705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651145705?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:30","pubTimestamp":1784115011,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0VO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNTI","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651450849","title":"Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable Genetic Medicines Powered by its Regulator Dial™ Technology Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2651450849","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651450849?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:30","pubTimestamp":1784115000,"startTime":"0","endTime":"0","summary":"Senti Biosciences Holdings, Inc. to Advance Controllable Cell and Gene Therapies Leveraging the Regulator Dial PlatformSpin-off of Senti Biosciences, Inc., including SENTI-202, Aims to Unlock Value vi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/15/3327605/0/en/Senti-Biosciences-Holdings-Inc-Announces-a-Strategic-Transaction-to-Unlock-Value-for-its-Gene-Circuit-Enabled-Pipeline-Including-SENTI-202-and-to-Sharpen-its-Focus-on-Next-Generati.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI","SYNB","BK4139","MDCO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651457497","title":"NASDAQ Trade Halt Halt News Pending at 07:25 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2651457497","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651457497?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:25","pubTimestamp":1784114700,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 07:25 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nAQN2M82CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644034646","title":"BRIEF-Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2644034646","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644034646?lang=en_us&edition=fundamental","pubTime":"2026-06-19 06:37","pubTimestamp":1781822228,"startTime":"0","endTime":"0","summary":"BRIEF-Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder June 18  - Senti Biosciences Holdings Inc SNTI.O:OFFERING 15.97 MILLION SHARES OF COMMON STOCK FOR RESALE BY SELLING SECURITYHOLDER - SEC FILINGSource text: [ID:n0001193125-26-276079]Further company coverage: SNTI.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNTI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644397170","title":"Senti Biosciences - Offering 15.97 Mln Shares of Common Stock for Resale by Selling Securityholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2644397170","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644397170?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:06","pubTimestamp":1781816775,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","SNTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638540320","title":"Senti Biosciences unit issues USD 10 million senior secured convertible notes to Celadon Partners SPV 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2638540320","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638540320?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:03","pubTimestamp":1779825793,"startTime":"0","endTime":"0","summary":"Senti Biosciences Holdings’ subsidiary Senti Holdings sold USD 10 million of Senior Secured Convertible Notes to Celadon Partners SPV 24 on May 20, 2026.Acquiom Agency Services was appointed collateral agent for the notes in connection with the May 20 issuance.Senti entered registration rights, guarantee, and voting agreements tied to the financing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senti Biosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL70WXVV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","SNTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636969018","title":"Analysts Conflicted on These Healthcare Names: Senti Biosciences (SNTI), ALX Oncology Holdings (ALXO) and Argenx Se (ARGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636969018","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636969018?lang=en_us&edition=fundamental","pubTime":"2026-05-18 00:40","pubTimestamp":1779036031,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Senti Biosciences (SNTI), ALX Oncology Holdings (ALXO) and Argenx...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-senti-biosciences-snti-alx-oncology-holdings-alxo-and-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-senti-biosciences-snti-alx-oncology-holdings-alxo-and-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU2324357040.USD","BK4585","IE0002141913.USD","LU0109394709.USD","BK4080","LU1983260115.SGD","IE00B2B36J28.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","ARGX","IE00BJT1NW94.SGD","BK4588","ALX","BK4539","XBI","BK4505","BK4581","LABU","HCSG","IE0009355771.USD","ALXO","LU0029874061.USD","LU0128526141.USD","IE0034235188.USD","BK4137","SNTI","IE00BFTCPJ56.SGD","BK4139","XLV","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635057876","title":"Senti Biosciences Faces Severe Refinancing and Liquidity Risks from Costly Note Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2635057876","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635057876?lang=en_us&edition=fundamental","pubTime":"2026-05-16 14:00","pubTimestamp":1778911225,"startTime":"0","endTime":"0","summary":"Senti Biosciences, Inc. (SNTI) has disclosed a new risk, in the Debt & Financing category. Senti Biosciences, Inc. faces considerable refinancing a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/senti-biosciences-faces-severe-refinancing-and-liquidity-risks-from-costly-note-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/senti-biosciences-faces-severe-refinancing-and-liquidity-risks-from-costly-note-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","SNTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635908428","title":"Senti Biosciences Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2635908428","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635908428?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:27","pubTimestamp":1778848020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SNTI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2026 08:27 ET (12:27 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","SNTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081089","title":"Chardan Raises Price Target on Senti Biosciences to $12 From $11, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081089","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081089?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:05","pubTimestamp":1778846737,"startTime":"0","endTime":"0","summary":"Chardan Raises Price Target on Senti Biosciences to $12 From $11, Keeps Buy Rating","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635710552","title":"Senti Biosciences Q1 net loss narrows on cost reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2635710552","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635710552?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:54","pubTimestamp":1778763295,"startTime":"0","endTime":"0","summary":"Senti Biosciences Q1 net loss narrows on cost reductionOverviewUS biotechnology firm's Q1 revenue beat analyst expectationsNet loss narrowed yr/yr, aided by $6.9 mln gain from lease modificationOutloo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL1N41R0NX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sentibio.com","stockEarnings":[{"period":"1week","weight":0.0504},{"period":"1month","weight":-0.0289},{"period":"3month","weight":-0.6894},{"period":"6month","weight":-0.6267},{"period":"1year","weight":-0.8066},{"period":"ytd","weight":-0.6894}],"compareEarnings":[{"period":"1week","weight":0.0195},{"period":"1month","weight":0.0116},{"period":"3month","weight":0.0452},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1425}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.037903},{"month":2,"riseRate":0.2,"avgChangeRate":-0.117173},{"month":3,"riseRate":0.2,"avgChangeRate":-0.07377},{"month":4,"riseRate":0.4,"avgChangeRate":-0.016933},{"month":5,"riseRate":0.4,"avgChangeRate":-0.057207},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.225173},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.015033},{"month":8,"riseRate":0.5,"avgChangeRate":-0.081451},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.103029},{"month":10,"riseRate":0.666667,"avgChangeRate":0.032697},{"month":11,"riseRate":0.4,"avgChangeRate":0.12033},{"month":12,"riseRate":0.4,"avgChangeRate":0.047383}],"exchange":"NASDAQ","name":"Senti Biosciences, Inc.","nameEN":"Senti Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Senti Biosciences, Inc.(SNTI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Senti Biosciences, Inc.(SNTI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Senti Biosciences, Inc.,SNTI,Senti Biosciences, Inc.股票,Senti Biosciences, Inc.股票老虎,Senti Biosciences, Inc.股票老虎国际,Senti Biosciences, Inc.行情,Senti Biosciences, Inc.股票行情,Senti Biosciences, Inc.股价,Senti Biosciences, Inc.股市,Senti Biosciences, Inc.股票价格,Senti Biosciences, Inc.股票交易,Senti Biosciences, Inc.股票购买,Senti Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Senti Biosciences, Inc.(SNTI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Senti Biosciences, Inc.(SNTI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction